USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$336.61M
Market Cap
24.35
P/E Ratio
0.62
EPS
$21.10
52 Week High
$8.61
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $217M |
| Total Revenue | $293M |
| Cost Of Revenue | $76M |
| Costof Goods And Services Sold | $76M |
| Operating Income | $22M |
| Selling General And Administrative | $71M |
| Research And Development | $8.8M |
| Operating Expenses | $192M |
| Investment Income Net | - |
| Net Interest Income | $1.3M |
| Interest Income | $3.4M |
| Interest Expense | $2.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $6.8M |
| Income Before Tax | $23M |
| Income Tax Expense | $6.5M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $17M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $26M |
| Ebitda | $32M |
| Net Income | $17M |
| Field | Value (USD) |
|---|---|
| Total Assets | $298M |
| Total Current Assets | $178M |
| Cash And Cash Equivalents At Carrying Value | $94M |
| Cash And Short Term Investments | $94M |
| Inventory | $19M |
| Current Net Receivables | $45M |
| Total Non Current Assets | $120M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $43M |
| Intangible Assets Excluding Goodwill | $43M |
| Goodwill | $31M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $15M |
| Other Current Assets | $5.1M |
| Other Non Current Assets | - |
| Total Liabilities | $81M |
| Total Current Liabilities | $41M |
| Current Accounts Payable | $5.6M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $5.9M |
| Total Non Current Liabilities | $41M |
| Capital Lease Obligations | $19M |
| Long Term Debt | $23M |
| Current Long Term Debt | $3M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $45M |
| Other Current Liabilities | $32M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $217M |
| Treasury Stock | - |
| Retained Earnings | $36M |
| Common Stock | $24K |
| Common Stock Shares Outstanding | $24M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $41M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $6.8M |
| Capital Expenditures | $2.5M |
| Change In Receivables | - |
| Change In Inventory | $3.9M |
| Profit Loss | - |
| Cashflow From Investment | -$2.5M |
| Cashflow From Financing | -$4.8M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$3.5M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $17M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $217M |
| Total Revenue | $293M |
| Cost Of Revenue | $76M |
| Costof Goods And Services Sold | $76M |
| Operating Income | $22M |
| Selling General And Administrative | $71M |
| Research And Development | $8.8M |
| Operating Expenses | $192M |
| Investment Income Net | - |
| Net Interest Income | $1.3M |
| Interest Income | $3.4M |
| Interest Expense | $2.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $6.8M |
| Income Before Tax | $23M |
| Income Tax Expense | $6.5M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $17M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $26M |
| Ebitda | $32M |
| Net Income | $17M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Tactile Systems Technology, Inc. (Ticker: TCMD) is an innovative medical technology company based in Minneapolis, Minnesota, specializing in the development and commercialization of therapeutic devices for the management of chronic conditions, particularly lymphedema and venous insufficiency. With a commitment to improving patient outcomes through advanced healthcare solutions, Tactile's proprietary products leverage cutting-edge technology to enhance the quality of life for patients across the United States. The company's strategic focus on expanding its product portfolio and market presence positions it as a significant player within the medical device industry, appealing to institutional investors seeking growth opportunities in the healthcare sector.